$SPDR標普生物科技ETF(XBI.US)$ The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023. As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
$Checkpoint Therapeutics(CKPT.US)$Yes CKPT got a CRL 12/18/23 for the place drug is manufactured. And partner with$Fortress Biotech(FBIO.US)$. My post came from FDA calendar as late as 1/2/24? They both have several drugs in pipeline! i try as hard as i can to post only factual information! I see no info that FBIO got any recent response from FDA? And thats why i posted. That and i seen still on calendar! So now i cant find positive information and need to delete...
$T2 Biosystems(TTOO.US)$no one can denied how strong is this company ! lot of catalyst coming and as i predicted the earning will be insane but i could be wrong ! like i said they still have 156m share to dilute before the RS at Nov and definitely we hope for the best to go 1+ before RS 🚀🚀🚀 none of the company has more FDA than TTOO! $T Stamp(IDAI.US)$lot more patent coming in ! this is long term hold for me or u can take profit to secure ur play! Dont follow me i have my str...
Checkpoint Therapeutics股票討論區
$OptiNose(OPTN.US)$
when are the next date for $Checkpoint Therapeutics(CKPT.US)$ , $Fortress Biotech(FBIO.US)$ , and $Brainstorm Cell Therapeutics(BCLI.US)$ ?
all of these stocks currently not good fundamentally... some even minus PBV
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US)$ by ...
$Arcutis Biotherapeutics(ARQT.US)$ : Approved 12/15
• ZORYVE® (Roflumilast foam 0.3%)
⇒ topical foam
⇒ PDUFA: 12/16/23
⇒ NDA
⇒ Seborrheic dermatitis
$默沙東(MRK.US)$ : Approved 12/15
• KEYTRUDA (pembrolizumab) + Padcev (enfortumab vedotin-ejfv)
⇒ IV injection
⇒ PDUFA: 05/09/24
⇒ sBLA
⇒ Urothelial cancer
$Glaukos(GKOS.US)$ : Approved 12/14
• iDose® TR (travoprost)
⇒ intracameral implant
⇒ PDUFA: 12/22/23
⇒ NDA
⇒ Glaucoma
$默沙東(MRK.US)$ : Approved ...
woah... silence creeper triggered my selling price
$T Stamp(IDAI.US)$ lot more patent coming in ! this is long term hold for me or u can take profit to secure ur play! Dont follow me i have my str...
暫無評論